APO-AMOXI FOR ORAL SUSPENSION 125 mg/5 ml
Product details
Registration number: SIN01664P
Classification: Prescription Only
Active ingredients: AMOXYCILLIN TRIHYDRATE EQV AMOXYCILLIN
Strength: 125 mg/5 ml
Dosage form: POWDER, FOR SUSPENSION
Route: ORAL
Registrant: PHARMAFORTE SINGAPORE PTE LTD
ATC code: J01CA04
HSA approval date: 7 June 1988
Manufacturer(s): APO-BIOTICS LIMITED
Manufacturing country/countries: CANADA
What are the HSA registration number and classification for APO-AMOXI FOR ORAL SUSPENSION 125 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN01664P
Classification: Prescription Only
What active ingredients and strength are recorded for APO-AMOXI FOR ORAL SUSPENSION 125 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Active ingredients: AMOXYCILLIN TRIHYDRATE EQV AMOXYCILLIN
Strength: 125 mg/5 ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for APO-AMOXI FOR ORAL SUSPENSION 125 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Dosage form: POWDER, FOR SUSPENSION
Route: ORAL
Who is the recorded registrant for APO-AMOXI FOR ORAL SUSPENSION 125 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Registrant: PHARMAFORTE SINGAPORE PTE LTD
Which manufacturers and countries are listed for APO-AMOXI FOR ORAL SUSPENSION 125 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): APO-BIOTICS LIMITED
Manufacturing country/countries: CANADA
Where can I look up APO-AMOXI FOR ORAL SUSPENSION 125 mg/5 ml in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN01664P or the exact product name APO-AMOXI FOR ORAL SUSPENSION 125 mg/5 ml. The general register link does not preselect this product.
What are the source dates for this APO-AMOXI FOR ORAL SUSPENSION 125 mg/5 ml record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this APO-AMOXI FOR ORAL SUSPENSION 125 mg/5 ml record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN01664P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)